(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient’s knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study)

INTRODUCTION: Current treatment decision-making in high-grade soft-tissue sarcoma (STS) care is not informed by individualised risks for different treatment options and patients’ preferences. Risk prediction tools may provide patients and professionals insight in personalised risks and benefits for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruiswijk, Anouk A, van de Sande, Michiel A J, Haas, Rick L, van den Akker-van Marle, Elske M, Engelhardt, Ellen G, Marang-van de Mheen, Perla, van Bodegom-Vos, Leti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626817/
https://www.ncbi.nlm.nih.gov/pubmed/37918933
http://dx.doi.org/10.1136/bmjopen-2023-074853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626817/
https://www.ncbi.nlm.nih.gov/pubmed/37918933
http://dx.doi.org/10.1136/bmjopen-2023-074853

Ejemplares similares